CDXS – Codexis, Inc.
Codexis, Inc.CDXS
$4.18Name : Codexis, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $340,159,616.00
EPSttm : -0.88
Codexis, Inc.
$4.18
1.88%$0.08Float Short %
3.74
Margin Of Safety %
Put/Call OI Ratio
0.05
EPS Next Q Diff
0.12
EPS Last/This Y
EPS This/Next Y
0.05
Price
4.17
Target Price
7.14
Analyst Recom
1.5
Performance Q
6.36
Relative Volume
0.99
Beta
2.08
Ticker: CDXS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | CDXS | 4.97 | 0.01 | 999.99 | 1421 |
| 2025-01-24 | CDXS | 4.91 | 0.01 | 0.00 | 1422 |
| 2025-01-27 | CDXS | 4.72 | 0.01 | 0.00 | 1432 |
| 2025-01-28 | CDXS | 4.59 | 0.01 | 0.00 | 1432 |
| 2025-01-29 | CDXS | 4.47 | 0.01 | 10.00 | 1472 |
| 2025-01-30 | CDXS | 4.51 | 0.01 | 10.00 | 1472 |
| 2025-01-31 | CDXS | 4.18 | 0.02 | 999.99 | 1483 |
| 2025-02-03 | CDXS | 4.28 | 0.02 | 0.23 | 1484 |
| 2025-02-04 | CDXS | 4.45 | 0.02 | 0.00 | 1510 |
| 2025-02-05 | CDXS | 4.36 | 0.02 | 0.14 | 2034 |
| 2025-02-06 | CDXS | 4.39 | 0.02 | 0.00 | 2042 |
| 2025-02-07 | CDXS | 4.31 | 0.02 | 0.00 | 2045 |
| 2025-02-10 | CDXS | 4.18 | 0.02 | 0.00 | 2044 |
| 2025-02-11 | CDXS | 4.14 | 0.02 | 0.00 | 2043 |
| 2025-02-12 | CDXS | 4.11 | 0.02 | 0.83 | 2069 |
| 2025-02-13 | CDXS | 4.11 | 0.04 | 1.25 | 2129 |
| 2025-02-14 | CDXS | 4.3 | 0.05 | 0.00 | 2146 |
| 2025-02-18 | CDXS | 4.39 | 0.05 | 0.00 | 2158 |
| 2025-02-19 | CDXS | 4.23 | 0.05 | 0.00 | 2158 |
| 2025-02-20 | CDXS | 4.25 | 0.05 | 0.00 | 2158 |
| 2025-02-21 | CDXS | 4.17 | 0.05 | 0.00 | 2164 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | CDXS | 4.98 | 79.1 | - | -0.69 |
| 2025-01-24 | CDXS | 4.91 | 79.1 | - | -0.69 |
| 2025-01-27 | CDXS | 4.72 | 79.1 | - | -0.69 |
| 2025-01-28 | CDXS | 4.58 | 79.1 | - | -0.69 |
| 2025-01-29 | CDXS | 4.48 | 79.1 | - | -0.69 |
| 2025-01-30 | CDXS | 4.50 | 79.1 | - | -0.69 |
| 2025-01-31 | CDXS | 4.18 | 79.1 | - | -0.69 |
| 2025-02-03 | CDXS | 4.27 | 79.1 | - | -0.69 |
| 2025-02-04 | CDXS | 4.44 | 79.1 | - | -0.69 |
| 2025-02-05 | CDXS | 4.37 | 79.1 | - | -0.69 |
| 2025-02-06 | CDXS | 4.40 | 79.1 | - | -0.69 |
| 2025-02-07 | CDXS | 4.31 | 79.1 | - | -0.69 |
| 2025-02-10 | CDXS | 4.18 | 79.1 | - | -0.69 |
| 2025-02-11 | CDXS | 4.14 | 79.1 | - | -0.69 |
| 2025-02-12 | CDXS | 4.10 | 79.1 | - | -0.69 |
| 2025-02-13 | CDXS | 4.11 | 79.1 | - | -0.69 |
| 2025-02-14 | CDXS | 4.31 | 79.1 | - | -0.69 |
| 2025-02-18 | CDXS | 4.39 | 79.1 | - | -0.69 |
| 2025-02-19 | CDXS | 4.23 | 79.1 | - | -0.69 |
| 2025-02-20 | CDXS | 4.25 | 79.1 | - | -0.69 |
| 2025-02-21 | CDXS | 4.17 | 79.1 | - | -0.69 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | CDXS | 142.75 | 9.83 | 2.90 |
| 2025-01-24 | CDXS | 142.75 | 9.83 | 2.90 |
| 2025-01-27 | CDXS | 142.75 | 11.09 | 2.90 |
| 2025-01-28 | CDXS | 142.75 | 11.09 | 3.01 |
| 2025-01-29 | CDXS | 142.75 | 11.09 | 3.01 |
| 2025-01-30 | CDXS | 142.75 | 11.09 | 3.01 |
| 2025-01-31 | CDXS | 142.75 | 11.09 | 3.01 |
| 2025-02-03 | CDXS | 161.17 | 9.47 | 3.01 |
| 2025-02-04 | CDXS | 161.17 | 9.47 | 3.01 |
| 2025-02-05 | CDXS | 152.48 | 9.47 | 3.01 |
| 2025-02-06 | CDXS | 152.48 | 9.47 | 3.01 |
| 2025-02-07 | CDXS | 152.48 | 9.47 | 3.01 |
| 2025-02-10 | CDXS | 152.48 | 11.83 | 3.01 |
| 2025-02-11 | CDXS | 152.48 | 11.83 | 3.01 |
| 2025-02-12 | CDXS | 152.48 | 11.83 | 3.74 |
| 2025-02-13 | CDXS | 167.23 | 11.83 | 3.74 |
| 2025-02-14 | CDXS | 118.69 | 11.83 | 3.75 |
| 2025-02-18 | CDXS | 118.69 | 14.36 | 3.74 |
| 2025-02-19 | CDXS | 175.57 | 14.36 | 3.74 |
| 2025-02-20 | CDXS | 175.57 | 14.36 | 3.74 |
| 2025-02-21 | CDXS | 175.57 | 14.36 | 3.74 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.29
Avg. EPS Est. Current Quarter
-0.02
Avg. EPS Est. Next Quarter
-0.17
Insider Transactions
175.57
Institutional Transactions
14.36
Beta
2.08
Average Sales Estimate Current Quarter
27
Average Sales Estimate Next Quarter
13
Fair Value
Quality Score
29
Growth Score
33
Sentiment Score
95
Actual DrawDown %
90.1
Max Drawdown 5-Year %
-96.4
Target Price
7.14
P/E
Forward P/E
PEG
P/S
5.28
P/B
4.63
P/Free Cash Flow
EPS
-0.88
Average EPS Est. Cur. Y
-0.69
EPS Next Y. (Est.)
-0.64
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-96.35
Relative Volume
0.99
Return on Equity vs Sector %
-103.8
Return on Equity vs Industry %
-88.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
Codexis, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 174
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
stock quote shares CDXS – Codexis, Inc. Stock Price stock today
news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CDXS – Codexis, Inc. yahoo finance google finance
stock history CDXS – Codexis, Inc. invest stock market
stock prices CDXS premarket after hours
ticker CDXS fair value insiders trading